During the past decade, Carolina ENT conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolina ENT" #1 collaborator was "Abond CRO Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Carolina ENT" are "Bilateral Nasal Polyposis" (1 trials), "Cow Milk Allergy" (1 trials) and "Otomycosis" (1 trials). Many other conditions were trialed in "Carolina ENT" in a lesser frequency.

Most popular intervention types in "Carolina ENT" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Control extensively hydrolyzed formula" (1 trials), "OPN-375" (1 trials), "Test extensively hydrolyzed formula" (1 trials), "miconazole 2% oil" (1 trials) and "vehicle oil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carolina ENT" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Carolina ENT". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Carolina ENT, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Carolina ENT, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".